GLP-1 questions: prescriptions, NHS access & costs

PCOS is now called polyendocrine metabolic ovarian syndrome (PMOS). The diagnosis alone does not guarantee a prescription. England’s phased primary-care tirzepatide pathway names hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes as its five qualifying conditions; PCOS itself is not on that list. A person with PCOS may also have those conditions. Other NHS pathways, UK nations and private assessments have different criteria. NHS England commissioning criteria ↗ PCOS to PMOS name change ↗

Start with your GP or a local weight-management service to discuss assessment and NHS routes. Private services may offer online consultations, local appointments or pharmacy collection; these are different arrangements. A nearby pharmacy does not necessarily prescribe or have a particular medicine in stock. Find the right local or online route.

A qualified prescribing healthcare professional must assess whether treatment is appropriate. Give accurate information about your health and current medicines through the provider’s secure process. NHS and private access have different criteria and arrangements. Paying for an assessment does not guarantee a prescription. MHRA patient guidance ↗

Yes, some legitimate services operate online, but an assessment and appropriate checks are still required. Ask how identity, relevant health information, follow-up and communication with your usual clinician are handled. Use a legitimate pharmacy with a prescription; do not buy prescription medicines from an unverified social-media seller. MHRA: obtaining genuine medicines ↗

Possibly, following assessment and the applicable local pathway. NHS England describes a phased rollout of tirzepatide in primary care, initially prioritising people with the highest clinical need. Other medicines have their own access criteria. England’s pathway should not be assumed to apply throughout the UK; ask your GP or local health service. NHS England access information ↗

A threshold is only part of the assessment. The prescriber considers the medicine’s indication, relevant conditions, other medicines and risks. We do not collect your medical history or calculate eligibility. NHS semaglutide information explains that access is subject to clinical criteria.

Check the exact medication, strength and supply period, then ask about assessment, delivery, needles or other supplies, ongoing reviews and compulsory fees. Introductory prices can differ from repeat orders. A four-week supply and a calendar-month subscription are not the same billing basis. Use the budgeting tools with a confirmed quote.

Read the eligibility, expiry, minimum commitment and repeat-order price. A scale, coaching session or discount is useful only if its conditions suit your needs. We report stated inclusions and terms; they do not establish that the treatment or provider is clinically appropriate.

Identify both the prescribing service and the dispensing pharmacy. Verify their relevant professional or service registrations and check that the listed contact details match. In Great Britain, pharmacies must be registered with the GPhC; Northern Ireland uses its own pharmacy regulator. A directory listing here is not accreditation. General Pharmaceutical Council ↗ Pharmaceutical Society of Northern Ireland ↗

No: these are prescription medicines. Avoid sellers who bypass a legitimate assessment or offer prescription products without a prescription. The MHRA warns that fake medicines can cause serious harm. MHRA safety advice ↗

Ask what evidence of your current prescription and recent treatment the receiving clinician needs, whether transfer assessment costs extra, and how continuity will be handled. Acceptance is not automatic. Do not choose or change a dose using a price table; ask your clinician.

Do not assume it does. Ask the dispensing provider about your delivery area, cold-chain arrangements, timing, collection options and any surcharge before paying. Nationwide marketing language may not explain every delivery exception. Individual profiles link to the source provider so you can confirm.

Contact your prescribing team or pharmacist for clinical advice and follow the patient information supplied with the medicine. In a medical emergency call 999; use your local urgent-care service for urgent non-emergency help. This publication cannot assess symptoms. Suspected side effects can also be reported via the MHRA Yellow Card scheme.